Xtacy Therapeutics Corp. (TT5.F)

0.0170 -0.0020 (-10.53%) As of 08:10AM CEST. Market open.

Xtacy Therapeutics Corp.

702 – 595 Howe Street
Vancouver, BC V6C 2E5
Canada
604-484-0355
https://xtacytherapeutics.com

Sector(s): Financial Services
Industry: Credit Services
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Ms. Meris Kott	Chairman, CEO & President	81.86k	N/A	N/A
Mr. Lindsey R. Perry Jr.	CFO & Director	N/A	N/A	1954
Mr. Stephen John Brohman B.B.A., C.A., CPA, CA, CPA	Consultant	N/A	N/A	1984
Mr. Mark Slaugh	Compliance Manager	N/A	N/A	N/A
Dr. Sudhanshu Agarwal B.Sc.	Chief Medical Advisor	N/A	N/A	1976
Ms. Eva Ulicna	Corporate Secretary	N/A	N/A	N/A
Tian Ma	Controller	N/A	N/A	N/A
Dr. Robert Klein	Strategic Medical Business Advisor	N/A	N/A	N/A
Ms. Leah Kincaid	Business Advisor	N/A	N/A	N/A
Mr. Darryl Davies B.Sc.	Business Advisor	N/A	N/A	N/A

Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

Xtacy Therapeutics Corp. formerly known as Global Wellness Strategies Inc. is an incubator, venture capital and accelerator firm specializing in incubation and startup. The firm seeks to invest in the public and private sectors that focus on preventative health, wellness issues, related consumer products, biotechnology, specific areas of pain, Psychedelic, depression, mental illness health and medicine sectors. By investing in pioneering techniques such as micro-dosing using organic compounds and synthetic molecules, we are focussing on ground breaking research with the aim of providing superior wellness benefits with less side effects, better for peoples and the planet. The firm seeks to invest in Canada. The firm also provides debt financing facility. Xtacy Therapeutics Corp. was incorporated in 1998 and is headquartered in Vancouver, Canada with an additional office in Vancouver, Canada.

Corporate governance

Xtacy Therapeutics Corp.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.